BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/3/2025 9:10:08 AM | Browse: 32 | Download: 156
 |
Received |
|
2025-07-28 13:37 |
|
Peer-Review Started |
|
2025-07-28 13:37 |
|
First Decision by Editorial Office Director |
|
2025-09-23 09:45 |
|
Return for Revision |
|
2025-09-23 09:45 |
|
Revised |
|
2025-10-02 08:14 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-10-31 02:32 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-10-31 07:23 |
|
Articles in Press |
|
2025-10-31 07:23 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-11-26 01:10 |
|
Publish the Manuscript Online |
|
2025-12-03 09:10 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Editorial |
| Article Title |
Emerging role of lisocabtagene maraleucel chimeric antigen receptor-T cell in nodal and gastrointestinal follicular lymphoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Takuya Watanabe |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Takuya Watanabe, Director, MD, PhD, Department of Internal Medicine and Gastroenterology, Watanabe Internal Medicine Aoyama Clinic, 1-2-21 Aoyama, Nishi-ku, Niigata 9502002, Japan. nabetaku@dia-net.ne.jp |
| Key Words |
Chimeric antigen receptor-T cell therapy; Lisocabtagene maraleucel; Follicular lymphoma; Gastrointestinal follicular lymphoma; Nodal follicular lymphoma |
| Core Tip |
Chimeric antigen receptor (CAR)-T therapy, particularly lisocabtagene maraleucel (liso-cel), offers a promising option for patients with relapsed or refractory and relapsed follicular lymphoma (FL), demonstrating high response rates and a favorable safety profile in the TRANSCEND FL trial. Compared to other CAR-T products, liso-cel shows advantages in toxicity, logistics, and feasibility. This editorial emphasizes its relevance for gastrointestinal FL, a subgroup often underrepresented in studies, and calls for broader inclusion and real-world validation to optimize CAR-T use across FL subtypes. |
| Publish Date |
2025-12-03 09:10 |
| Citation |
Watanabe T. Emerging role of lisocabtagene maraleucel chimeric antigen receptor-T cell in nodal and gastrointestinal follicular lymphoma. World J Gastroenterol 2025; 31(45): 112336 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i45/112336.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i45.112336 |
© 2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
